Coronavirus | Govt. exploring ways for emergency authorisation

 thehindu.com  11/22/2020 18:03:07 

The Union government is exploring the modalities of emergency authorisation and usage of anti-coronavirus vaccines pending completion of Phase 3 clinical trial and regular licensure.

The issue of advance purchase commitment for vaccines, including pricing, was also discussed at a recent meeting attended by NITI Aayog Member (Health) Vinod Paul, Principal Scientific Advisor to the government K VijayRaghavan and Union Health Secretary Rajesh Bhushan.

Market commitment

It was decided that the PMO-constituted Vaccine Task Force (VTF) will lay down the principles for emergency use authorisation, while the National Expert Group On Vaccine Administration for COVID-19 (NEGVAC) should take the lead in setting the principles for advance market commitment, including vaccine pricing, a source said.

These developments assume significance against the backdrop of Pfizer seeking emergency use authorisation of its COVID-19 vaccine from the US regulators. Another U.S.-based biotechnology giant, Moderna, said it also intended to apply for an emergency use authorisation (EUA) with the U.S. Food and Drug Administration (USFDA) in the coming weeks.

According to the source, an urgent meeting of the vaccine task force (VTF) with experts will be convened to review the scientific status of vaccines globally and how and when should the decision on emergency authorisation of vaccines be taken.

Terms of references

The terms of references for two major bodies dealing with vaccine introduction  the National Technical Advisory Group on Immunisation (NTAGI) and the Central Drug Standards and Control Organisation (CDSCO)  will be set and their roles clearly defined for authorisation and emergency authorisation.

It was also agreed at the meeting that one point of contact would be responsible for examining and responding to authorisations given (or in the pipeline), globally, the source said.

Dear reader,

We have been keeping you up-to-date with information on the developments in India and the world that have a bearing on our health and wellbeing, our lives and livelihoods, during these difficult times. To enable wide dissemination of news that is in public interest, we have increased the number of articles that can be read free, and extended free trial periods. However, we have a request for those who can afford to subscribe: please do. As we fight disinformation and misinformation, and keep apace with the happenings, we need to commit greater resources to news gathering operations. We promise to deliver quality journalism that stays away from vested interest and political propaganda.

Support Quality Journalism

Dear subscriber,

Thank you!

Your support for our journalism is invaluable. Its a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.

The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.

We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.

Suresh Nambath

« Go back